tetano
Editor, Senior Moderator
Am J Transplant. 2020 Apr 13. doi: 10.1111/ajt.15919. [Epub ahead of print]
First case of COVID-19 in a kidney transplant recipient treated with belatacept.
Marx D[SUP]1[/SUP], Moulin B[SUP]1[/SUP], Fafi-Kremer S[SUP]2[/SUP], Benotmane I[SUP]1,[/SUP][SUP]2[/SUP], Gautier G[SUP]1[/SUP], Perrin P[SUP]1[/SUP], Caillard S[SUP]1[/SUP].
Author information
Abstract
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing public health emergency of international concern. Acute respiratory distress syndrome (ARDS) develops in 3-30% of patients with COVID-19 (1,2), because of direct virus-induced cytopathic effects in the respiratory tract or cytokine storms triggered by the host's immune response. Comorbidities are known to increase the risk of ARDS in SARS-CoV-2-infected patients (1).
This article is protected by copyright. All rights reserved.
PMID:32282977DOI:10.1111/ajt.15919
First case of COVID-19 in a kidney transplant recipient treated with belatacept.
Marx D[SUP]1[/SUP], Moulin B[SUP]1[/SUP], Fafi-Kremer S[SUP]2[/SUP], Benotmane I[SUP]1,[/SUP][SUP]2[/SUP], Gautier G[SUP]1[/SUP], Perrin P[SUP]1[/SUP], Caillard S[SUP]1[/SUP].
Author information
Abstract
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing public health emergency of international concern. Acute respiratory distress syndrome (ARDS) develops in 3-30% of patients with COVID-19 (1,2), because of direct virus-induced cytopathic effects in the respiratory tract or cytokine storms triggered by the host's immune response. Comorbidities are known to increase the risk of ARDS in SARS-CoV-2-infected patients (1).
This article is protected by copyright. All rights reserved.
PMID:32282977DOI:10.1111/ajt.15919